Search for: "Deas v. Deas" Results 41 - 60 of 813
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Mar 2023, 9:31 am by Aaron Black
Here, a telehealth practitioner may prescribe up to a 30-day supply of a schedule III-V non-narcotic controlled medication. [read post]
7 Mar 2023, 7:14 am by Alan J. Arville
Notably, the proposed rules also give DEA-registered practitioners who have relied on the DEA’s emergency waiver—which, since January 2020, has allowed practitioners to prescribe Schedules II-V controlled substances without conducting a prior in-person medical evaluation of the patient—up to 180 days to come into compliance with the new in-person evaluation requirements that would be implemented in the final regulations. [read post]
2 Mar 2023, 9:05 pm by Bryn Hines
Supreme Court’s decision in Dobbs v. [read post]
1 Mar 2023, 8:00 am by Erin Sutton
Under the proposed rules, where a practitioner and patient established a telemedicine relationship during the PHE and where the practitioner, relying on the DEA waiver, prescribed Schedules II-V controlled substances to the patient without conducting an in-person medical evaluation of the patient, practitioners would be given 180-days to come into compliance with in-person evaluation requirements. [read post]
9 Nov 2022, 2:01 am by Florian Mueller
Other present defendants include AVM (a German Netgear competitor) and Amazon (presumably because of its WiFi-capable devices like Kindle and Echo).This Huawei v. [read post]